Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Norn Ventures is a UK-registered accelerator and venture capital fund that specializes in life sciences, medical technology, and health tech. Founded with a mission to assist early-stage companies in navigating the complexities of product launches, market expansion, and successful exits, Norn Ventures boasts over 150 years of combined commercial experience among its team. The firm primarily operates in the UK, Europe, and North America, focusing on high-potential opportunities in the healthcare sector.
The organization has established itself as a key player in the life sciences investment space, leveraging its extensive experience to guide startups through critical growth phases. Norn Ventures emphasizes a hands-on approach, providing strategic coaching and mentorship to its portfolio companies. The firm is dedicated to maximizing growth and success for its investments, ensuring that they are well-prepared for the challenges of the market.
Norn Ventures invests in early-stage companies within the life sciences and health tech sectors, specifically targeting pre-seed, seed, and seed-plus stages. Their investment strategy is characterized by a strong emphasis on providing strategic coaching, mentorship, and active involvement to help ventures mature and grow. The firm seeks high-potential opportunities that align with its expertise in healthcare innovation.
In addition to capital, Norn Ventures offers expert guidance on market entry, product launches, geographic expansion, exit strategy development, and regulatory navigation. This comprehensive support is designed to enhance the growth trajectory of portfolio companies, ensuring they are equipped to tackle the complexities of the healthcare market. Norn Ventures values founders who demonstrate a commitment to innovation and possess a clear vision for their companies.
Norn Ventures has a notable portfolio of five companies, each contributing to advancements in healthcare and medical technology:
This diverse portfolio reflects Norn Ventures' commitment to supporting innovative solutions in the healthcare sector, particularly in areas that enhance patient care and operational efficiency.
Mindy Daeschner - Managing Partner: Mindy has a background in health, insurance, and technology, with experience in global consultancy and corporate leadership. She has also advised numerous startups.
Barry Ritchie - Chief Investment Officer: Barry brings extensive experience in investment management and has a strong background in the life sciences sector.
Chris Howie - Partner: Chris has a proven track record in venture capital and has worked with various startups in the healthcare space.
Simon Checkley - Partner: Simon specializes in medical technology investments and has a background in operational management within the sector.
Kjell-Inge Arnevig - Strategic Advisor: Kjell-Inge provides strategic insights based on his extensive experience in the healthcare industry.
Matt Wood - Non-Executive Director: Matt contributes his expertise in corporate governance and strategic planning.
Brent James - Strategic Advisor: Brent offers guidance on regulatory matters and market entry strategies.
David McKinley - Strategic Advisor: David has a wealth of experience in healthcare investments and operational management.
To pitch Norn Ventures, founders should reach out through their website. A well-prepared pitch deck is essential, including details on the business model, market opportunity, and growth strategy. While specific response time expectations are not provided, founders should anticipate a thorough review process.
Norn Ventures runs an accelerator program designed to support early-stage companies in the life sciences and health tech sectors. This program provides participants with access to mentorship, strategic guidance, and resources necessary for successful product launches and market entry.
Eligibility for the program typically includes startups at the pre-seed or seed stages that demonstrate high growth potential in healthcare innovation. Interested founders can apply through the Norn Ventures website for consideration.
As of October 2023, Norn Ventures continues to expand its portfolio in the life sciences sector, focusing on innovative healthcare solutions. The firm has recently made investments in companies that align with its mission to enhance patient care and operational efficiency.
Notable recent activity includes the continued support of its existing portfolio companies, such as PocDoc and MediShout, as they expand their market presence. Norn Ventures remains committed to guiding its investments through critical growth phases, ensuring they are well-positioned for successful exits.
What are Norn Ventures' investment criteria?
Norn Ventures focuses on early-stage companies in the life sciences and health tech sectors, particularly those at the pre-seed, seed, and seed-plus stages. They look for high-potential opportunities that demonstrate a clear vision and commitment to innovation.
How can startups apply or pitch to Norn Ventures?
Startups interested in pitching to Norn Ventures should prepare a comprehensive deck that outlines their business model, market opportunity, and growth strategy. While specific application forms are not mentioned, reaching out through their website is recommended.
What makes Norn Ventures different from other investors?
Norn Ventures combines capital investment with extensive operational and regulatory guidance, leveraging over 150 years of combined experience in the life sciences sector. This unique approach helps startups navigate the complexities of product launches and market entry.
What geographic areas does Norn Ventures focus on?
The firm primarily operates in the UK, Europe, and North America, targeting high-potential healthcare opportunities across these regions.
What kind of post-investment involvement can founders expect?
Norn Ventures provides active involvement in portfolio companies, offering mentorship and strategic guidance to help them grow and succeed in the market. This includes support in areas such as product launches and exit strategies.
What is the typical check size for investments?
While specific check sizes are not disclosed, Norn Ventures invests at the pre-seed, seed, and seed-plus stages, indicating a focus on early-stage funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.